• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发、临床前评估和验证一种新型快速血管闭合装置,用于经腔、心脏和放射学动脉导管插入术。

Development, preclinical evaluation and validation of a novel quick vascular closure device for transluminal, cardiac and radiological arterial catheterization.

机构信息

German Institutes of Textile and Fiber Research (DITF), Denkendorf, Germany.

ITV Denkendorf Produktservice GmbH, Denkendorf, Germany.

出版信息

J Mater Sci Mater Med. 2018 Jun 11;29(6):83. doi: 10.1007/s10856-018-6092-y.

DOI:10.1007/s10856-018-6092-y
PMID:29892952
Abstract

Following percutaneous coronary intervention, vascular closure devices (VCDs) are increasingly used to reduce time to ambulation, enhance patient comfort, and reduce potential complications compared with traditional manual compression. Newer techniques include complicated, more or less automated suture devices, local application of pads or the use of metal clips and staples. These techniques often have the disadvantage of being time consuming, expensive or not efficient enough. The VCD failure rate in association with vascular complications of 2.0-9.5%, depending on the type of VCD, is still not acceptable. Therefore, the aim of this study is to develop a self-expanding quick vascular closure device (QVCD) made from a bioabsorbable elastic polymer that can be easily applied through the placed introducer sheath. Bioabsorbable block-co-polymers were synthesized and the chemical and mechanical degradation were determined by in vitro tests. The best fitting polymer was selected for further investigation and for microinjection moulding. After comprehensive haemocompatibility analyses in vitro, QVCDs were implanted in arterial vessels following arteriotomy for different time points in sheep to investigate the healing process. The in vivo tests proved that the new QVCD can be safely placed in the arteriotomy hole through the existing sheath instantly sealing the vessel. The degradation time of 14 days found in vitro was sufficient for vessel healing. After 4 weeks, the remaining QVCD material was covered by neointima. Overall, our experiments showed the safety and feasibility of applying this novel QVCD through an existing arterial sheath and hence encourage future work with larger calibers.

摘要

经皮冠状动脉介入治疗后,血管闭合装置(VCD)越来越多地被用于减少活动时间、增强患者舒适度,并减少与传统手动压缩相关的潜在并发症。较新技术包括复杂的、或多或少自动化的缝合装置、局部应用的垫子或使用金属夹和订书钉。这些技术往往具有耗时、昂贵或效率不够高的缺点。VCD 的血管并发症发生率为 2.0-9.5%,具体取决于 VCD 的类型,这仍然是不可接受的。因此,本研究的目的是开发一种由可生物吸收弹性聚合物制成的自扩张快速血管闭合装置(QVCD),可以通过放置的导入鞘轻松应用。合成了可生物吸收的嵌段共聚物,并通过体外试验确定了其化学和机械降解情况。选择最佳的聚合物进行进一步研究和微注射成型。在体外进行了全面的血液相容性分析后,将 QVCD 植入羊的动脉血管中,在不同的时间点进行动脉切开术,以研究愈合过程。体内试验证明,新的 QVCD 可以通过现有的护套安全地放置在动脉切开孔中,立即密封血管。在体外发现的 14 天降解时间足以使血管愈合。4 周后,剩余的 QVCD 材料被新生内膜覆盖。总的来说,我们的实验表明,通过现有的动脉护套应用这种新型 QVCD 是安全且可行的,因此鼓励未来使用更大口径进行进一步研究。

相似文献

1
Development, preclinical evaluation and validation of a novel quick vascular closure device for transluminal, cardiac and radiological arterial catheterization.开发、临床前评估和验证一种新型快速血管闭合装置,用于经腔、心脏和放射学动脉导管插入术。
J Mater Sci Mater Med. 2018 Jun 11;29(6):83. doi: 10.1007/s10856-018-6092-y.
2
AbsorbaSeal™ 5.6.7F vascular closure device: A good laboratory practice chronic study evaluating safety and efficacy in a healthy porcine model.AbsorbaSeal™ 5.6.7F 血管闭合装置:一项在健康猪模型中评估安全性和有效性的良好实验室规范慢性研究。
Vascular. 2022 Oct;30(5):934-942. doi: 10.1177/17085381211037883. Epub 2021 Aug 29.
3
Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.经股动脉穿刺后使用血管闭合装置与手动压迫的比较:ISAR-CLOSURE 随机临床试验。
JAMA. 2014 Nov 19;312(19):1981-7. doi: 10.1001/jama.2014.15305.
4
AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular Procedures.AbsorbaSeal™血管闭合装置:一种用于介入性外周血管手术后止血的新型装置。
Surg Technol Int. 2017 Oct 12;31:93-99.
5
A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).新型生物可吸收血管闭合装置与手动压迫用于经皮股动脉手术后止血效果的随机对照研究:ECLIPSE(确保血管闭合装置加速止血试验)
JACC Cardiovasc Interv. 2009 Aug;2(8):785-93. doi: 10.1016/j.jcin.2009.06.006.
6
Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.一项比较血管闭合装置与手动压迫在诊断性冠状动脉造影术后实现止血效果的随机临床试验的原理与设计:动脉穿刺部位器械封闭 - 闭合装置与手动压迫(ISAR-CLOSURE)试验
EuroIntervention. 2014 Jun;10(2):198-203. doi: 10.4244/EIJV10I2A33.
7
Mynx Vascular Closure Device in Arterial Endovascular Procedures.用于动脉血管内手术的Mynx血管闭合装置
Ann Vasc Surg. 2018 Jan;46:112-117. doi: 10.1016/j.avsg.2017.05.009. Epub 2017 May 22.
8
Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device.一种新型手术鞘管及闭合装置在诊断性心导管插入术中的疗效:FISH装置的多中心随机临床试验
J Invasive Cardiol. 2008 Apr;20(4):152-6.
9
Feasibility study of NeoMend, a percutaneous arterial closure device that uses a nonthrombogenic bioadhesive.NeoMend的可行性研究,一种使用非血栓形成生物粘合剂的经皮动脉闭合装置。
AJR Am J Roentgenol. 2003 Feb;180(2):533-8. doi: 10.2214/ajr.180.2.1800533.
10
Suture-mediated arterial access site closure after transfemoral aortic valve implantation.经缝合器缝合的经股动脉主动脉瓣植入术后动脉入路关闭。
Catheter Cardiovasc Interv. 2013 Feb;81(2):E139-50. doi: 10.1002/ccd.24326. Epub 2012 May 2.

引用本文的文献

1
Preclinical evaluation of vascular closure devices.血管闭合装置的临床前评估。
Front Cardiovasc Med. 2024 Nov 29;11:1502909. doi: 10.3389/fcvm.2024.1502909. eCollection 2024.

本文引用的文献

1
Vascular Closure Devices in Interventional Radiology Practice.
Cardiovasc Intervent Radiol. 2015 Aug;38(4):781-93. doi: 10.1007/s00270-015-1116-1. Epub 2015 May 6.
2
Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty.诊断性血管造影和血管成形术后血管闭合装置疗效的随机试验的荟萃分析。
Am Heart J. 2010 Apr;159(4):518-31. doi: 10.1016/j.ahj.2009.12.027.
3
Animal models for the assessment of novel vascular conduits.用于评估新型血管移植物的动物模型。
J Vasc Surg. 2010 Jul;52(1):176-95. doi: 10.1016/j.jvs.2009.10.080. Epub 2010 Mar 29.
4
A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).新型生物可吸收血管闭合装置与手动压迫用于经皮股动脉手术后止血效果的随机对照研究:ECLIPSE(确保血管闭合装置加速止血试验)
JACC Cardiovasc Interv. 2009 Aug;2(8):785-93. doi: 10.1016/j.jcin.2009.06.006.
5
An overview of vascular closure devices: what every radiologist should know.血管闭合装置概述:放射科医生应知应会。
Eur J Radiol. 2010 Jan;73(1):181-90. doi: 10.1016/j.ejrad.2008.09.023. Epub 2008 Nov 28.
6
Vascular closure devices: a comparative overview.血管闭合装置:比较综述。
Curr Probl Diagn Radiol. 2009 Jan-Feb;38(1):33-43. doi: 10.1067/j.cpradiol.2008.02.002.
7
Testing percutaneous arterial closure devices: an animal model.
Cardiovasc Intervent Radiol. 2009 Mar;32(2):313-6. doi: 10.1007/s00270-008-9426-1. Epub 2008 Sep 9.
8
Foreign body reaction to biomaterials.生物材料的异物反应
Semin Immunol. 2008 Apr;20(2):86-100. doi: 10.1016/j.smim.2007.11.004. Epub 2007 Dec 26.
9
Vascular closure devices: the second decade.血管闭合装置:第二个十年
J Am Coll Cardiol. 2007 Oct 23;50(17):1617-26. doi: 10.1016/j.jacc.2007.07.028.
10
Histologic and duplex comparison of the perclose and angio-seal percutaneous closure devices.Perclose和Angio-Seal经皮闭合装置的组织学与双功超声比较
Vascular. 2007 Jan-Feb;15(1):24-9. doi: 10.2310/6670.2007.00004.